Published in Neuroimage on October 10, 2013
How Relevant is Food Craving to Obesity and Its Treatment? Front Psychiatry (2014) 0.90
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study. Eur J Nucl Med Mol Imaging (2015) 0.81
Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans. Br J Pharmacol (2014) 0.80
Central nervous system regulation of eating: Insights from human brain imaging. Metabolism (2016) 0.79
The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight. Int J Obes (Lond) (2015) 0.78
Imaging human brown adipose tissue under room temperature conditions with (11)C-MRB, a selective norepinephrine transporter PET ligand. Metabolism (2015) 0.77
The Body Mass Index, Blood Pressure, and Fasting Blood Glucose in Patients With Methamphetamine Dependence. Medicine (Baltimore) (2016) 0.77
Maternal Prenatal Mental Health and Placental 11β-HSD2 Gene Expression: Initial Findings from the Mercy Pregnancy and Emotional Wellbeing Study. Int J Mol Sci (2015) 0.76
Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor. Int J Neuropsychopharmacol (2014) 0.76
Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain. Nucl Med Biol (2016) 0.75
Central noradrenaline transporter availability in highly obese, non-depressed individuals. Eur J Nucl Med Mol Imaging (2017) 0.75
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA (2012) 28.69
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
Brain dopamine and obesity. Lancet (2001) 8.00
Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry (2003) 7.11
Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA (2013) 4.30
The pulvinar regulates information transmission between cortical areas based on attention demands. Science (2012) 4.14
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab (2003) 3.77
Cortical and limbic activation during viewing of high- versus low-calorie foods. Neuroimage (2003) 2.71
Reward mechanisms in obesity: new insights and future directions. Neuron (2011) 2.21
Obesity and addiction: neurobiological overlaps. Obes Rev (2012) 1.99
Mechanisms of obesity-induced hypertension. Hypertens Res (2010) 1.85
Sleep restriction leads to increased activation of brain regions sensitive to food stimuli. Am J Clin Nutr (2012) 1.54
Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46
Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biol Psychiatry (2010) 1.44
Neural correlates of stress- and food cue-induced food craving in obesity: association with insulin levels. Diabetes Care (2012) 1.32
Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol (2000) 1.32
Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension. Obesity (Silver Spring) (2012) 1.23
PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT. Synapse (2010) 1.16
Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Synapse (2003) 1.15
Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates. Neuroimage (2010) 0.99
Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism (2001) 0.97
Anti-obesity drug development. Expert Opin Investig Drugs (2002) 0.97
Gender differences in the association between body mass index and psychopathology. CNS Spectr (2009) 0.93
Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future (2004) 0.92
Reduced paraventricular nucleus norepinephrine responsiveness in obesity-prone rats. Am J Physiol (1996) 0.92
Reduced norepinephrine turnover in organs and brains of obesity-prone rats. Am J Physiol (1995) 0.91
The medicalization of chronic disease and costs. Annu Rev Public Health (2012) 0.89
No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage (2012) 0.89
PET imaging of norepinephrine transporters. Curr Pharm Des (2006) 0.87
Reduction in neural activation to high-calorie food cues in obese endometrial cancer survivors after a behavioral lifestyle intervention: a pilot study. BMC Neurosci (2012) 0.80
Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO. Drug Alcohol Depend (2014) 0.91